BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38229370)

  • 21. Recent achievements in the management of Raynaud's phenomenon.
    Baumhäkel M; Böhm M
    Vasc Health Risk Manag; 2010 Apr; 6():207-14. PubMed ID: 20407628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Raynaud's phenomena: diagnostic and treatment study].
    Priollet P
    Rev Prat; 1998 Oct; 48(15):1659-64. PubMed ID: 9814067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine.
    Coleiro B; Marshall SE; Denton CP; Howell K; Blann A; Welsh KI; Black CM
    Rheumatology (Oxford); 2001 Sep; 40(9):1038-43. PubMed ID: 11561116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Raynaud's phenomenon.
    Wigley FM
    Curr Opin Rheumatol; 1993 Nov; 5(6):773-84. PubMed ID: 8117541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thermographic parameters in the diagnosis of secondary Raynaud's phenomenon.
    Schuhfried O; Vacariu G; Lang T; Korpan M; Kiener HP; Fialka-Moser V
    Arch Phys Med Rehabil; 2000 Apr; 81(4):495-9. PubMed ID: 10768542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Helicobacter pylori eradication ameliorates primary Raynaud's phenomenon.
    Gasbarrini A; Massari I; Serricchio M; Tondi P; De Luca A; Franceschi F; Ojetti V; Dal Lago A; Flore R; Santoliquido A; Gasbarrini G; Pola P
    Dig Dis Sci; 1998 Aug; 43(8):1641-5. PubMed ID: 9724144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregnancy outcomes in women with primary Raynaud's phenomenon.
    Kahl LE; Blair C; Ramsey-Goldman R; Steen VD
    Arthritis Rheum; 1990 Aug; 33(8):1249-55. PubMed ID: 2390127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occupational noise exposure and Raynaud's phenomenon: a nested case-control study.
    Stjernbrandt A; Abu Mdaighem M; Pettersson H
    Int J Circumpolar Health; 2021 Dec; 80(1):1969745. PubMed ID: 34415235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Raynaud's phenomenon.
    Devgire V; Hughes M
    Br J Hosp Med (Lond); 2019 Nov; 80(11):658-664. PubMed ID: 31707892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Raynaud's phenomenon of the nipple: a treatable cause of painful breastfeeding.
    Anderson JE; Held N; Wright K
    Pediatrics; 2004 Apr; 113(4):e360-4. PubMed ID: 15060268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study.
    DiGiacomo RA; Kremer JM; Shah DM
    Am J Med; 1989 Feb; 86(2):158-64. PubMed ID: 2536517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Raynaud's phenomenon in primary Sjögren's syndrome.
    Skopouli FN; Talal A; Galanopoulou V; Tsampoulas CG; Drosos AA; Moutsopoulos HM
    J Rheumatol; 1990 May; 17(5):618-20. PubMed ID: 2359071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study on the effectiveness of a corticosteroid injection for carpal tunnel syndrome in patients with and without Raynaud's phenomenon.
    Roh YH; Noh JH; Gong HS; Baek GH
    Bone Joint J; 2017 Dec; 99-B(12):1637-1642. PubMed ID: 29212687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic inflammation predicts long-term mortality in patients with Raynaud's phenomenon.
    Mueller M; Gschwandtner ME; Gamper J; Giurgea GA; Kiener HP; Perkmann T; Koppensteiner R; Schlager O
    J Intern Med; 2018 Mar; 283(3):293-302. PubMed ID: 29068146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postocclusive reactive hyperemia in hand-arm vibration syndrome.
    Stoyneva Z
    Int J Occup Med Environ Health; 2016; 29(4):659-66. PubMed ID: 27443761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Raynaud's phenomenon in systemic sclerosis-a practical approach.
    Fernández-Codina A; Cañas-Ruano E; Pope JE
    J Scleroderma Relat Disord; 2019 Jun; 4(2):102-110. PubMed ID: 35382396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can people with Raynaud's phenomenon travel to high altitude?
    Luks AM; Grissom CK; Jean D; Swenson ER
    Wilderness Environ Med; 2009; 20(2):129-38. PubMed ID: 19594214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The validity of Raynaud's phenomenon symptoms in HAVS cases.
    Youakim S
    Occup Med (Lond); 2008 Sep; 58(6):431-5. PubMed ID: 18567613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Digital cutaneous vascular responses to histamine and neuropeptides in Raynaud's phenomenon.
    Bunker CB; Foreman JC; Dowd PM
    J Invest Dermatol; 1991 Mar; 96(3):314-7. PubMed ID: 2002251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How to classify Raynaud's phenomenon. Long-term follow-up study of 73 cases.
    Priollet P; Vayssairat M; Housset E
    Am J Med; 1987 Sep; 83(3):494-8. PubMed ID: 3661586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.